TNGX Stock Analysis: Buy, Sell, or Hold?

TNGX - Tango Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS
$19.21
-0.05 (-0.26%) β–Ό
5d: +1.32%
30d: +72.44%
90d: +121.57%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation

TNGX is down 10.7% this week, but smart money is accumulating calls. Top strike: $10 2026-05-15 with 208 OI. Call ratio: 82% View Scanner →

Strength: 8.6/10

Get Alerted When TNGX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ’‘ BUY OPPORTUNITY: TNGX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.

In-depth Analysis How we analyze

Valuation Analysis: TNGX is currently trading at $19.21, which is considered slightly high relative to its 30-day fair value range of $12.90 to $19.28.

Technical Outlook: Technically, TNGX is in a strong uptrend. Immediate support is located at $17.52, while resistance sits at $21.82.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $12.90 - $19.28
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 61.6%

All Signals

  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($19.67)

Fair Price Analysis

30-Day Fair Range $12.90 - $19.28
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $17.52
Resistance Level $21.82
Current Trend Strong Uptrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) -12.57
Wall Street Target $19.67 (+2.1%)
Revenue Growth (YoY) -100.0%
Profit Margin -162.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 5:00 PM ET
Data refreshes hourly during market hours. Next update: 6:00 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam Crystal SELL 20251 shares 2026-03-05
Adam Crystal SELL 54345 shares 2026-02-25
Adam Crystal SELL 18452 shares 2026-02-03

Unlock Insider Activity

See real-time buying/selling by company executives for TNGX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$222 59 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$92 62 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$54 53 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$108 61 BUY
RVMD
Revolution Medicines Inc
STRONG BUY
12 analysts
$134 59 HOLD

Advanced TNGX Option Strategies

Professional options setups generated by AI based on today's TNGX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TNGX

TNGX Technical Chart TNGX Price Prediction TNGX Earnings Date TNGX Investment Advisor TNGX Fair Price Analyzer TNGX Options Advisor TNGX Options Chain TNGX Options Analysis TNGX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals